Sex steroid metabolism and actions in non-small cell lung carcinoma

•Association sex steroid actions including estrogen, estrogen intracrinology, progesterone, hormone replacement therapy and androgen in NSCLC.•Association sex steroid receptor actions including estrogen receptor, progesterone receptor and androgen receptor in NSCLC.•Association sex steroid receptor...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of steroid biochemistry and molecular biology 2019-10, Vol.193, p.105440-105440, Article 105440
Main Authors: Asavasupreechar, Teeranut, Chan, Monica S.M., Saito, Ryoko, Miki, Yasuhiro, Boonyaratanakornkit, Viroj, Sasano, Hironobu
Format: Article
Language:English
Subjects:
Animals
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - metabolism
Endocrine therapy
Gonadal Steroid Hormones - metabolism
Hormone Replacement Therapy
Humans
Lung
Lung cancer
Lung cancer treatment
Lung carcinoma
Lung Neoplasms - drug therapy
Lung Neoplasms - metabolism
Metabolism
Non-small cell lung carcinoma
Receptors, Androgen - metabolism
Receptors, Progesterone - metabolism
Sex
Sex steroid receptors
Sex steroids
Small cell lung carcinoma
Steroid hormones
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Association sex steroid actions including estrogen, estrogen intracrinology, progesterone, hormone replacement therapy and androgen in NSCLC.•Association sex steroid receptor actions including estrogen receptor, progesterone receptor and androgen receptor in NSCLC.•Association sex steroid receptor signaling pathway in NSCLC.•The possible treatment of NSCLC patients by modulating sex steroid signaling. Despite recent development in targeted therapies, lung cancer still remains the leading cause of cancer death. Therefore, a better understanding of its pathogenesis and progression could contribute to improving the eventual clinical outcome of the patients. Results of recently published several in vitro and clinical studies indicated the possible involvement of sex steroids in both development and progression of non-small cell lung carcinoma (NSCLC). Therefore we summarized the reported clinical relevant information of the sex steroids, their receptors and steroid metabolizing enzymes related to NSCLC in this mini-review. In addition, we also reviewed the potential “endocrine therapy”, targeting sex steroid actions and/or metabolism in NSCLC patients.
ISSN:0960-0760
1879-1220
DOI:10.1016/j.jsbmb.2019.105440